Navigation Links
Nanotechnology helps track and improve drug action in pancreatic cancer
Date:6/11/2013

UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.

In real time and in three dimensions, these technologies can show us how cancers spread and how active cancer cells respond to a particular drug. They can also tell us how much, how often and how long to administer drugs. Finally, using preclinical models of the disease, they can guide the use of 'combination therapies', techniques that enhance drug delivery by breaking up the tissue surrounding a tumour.

The study was performed by Dr Paul Timpson of the Garvan Institute of Medical Research and Professor Kurt Anderson of the Beatson Institute for Cancer Research in Glasgow, UK. PhD student Max Nobis studied the signaling protein 'Src', which becomes activated to drive invasive pancreatic cancer, and looked at how it could best be deactivated by a small molecule inhibitor currently in phase II clinical trials known as 'dasatinib'. Their findings are published in the journal Cancer Research, now online.

"We have already shown that Src is activated in pancreatic tumours and we knew that dasatinib deactivates Src and could partially reduce the spread of this form of cancer. Through a collaborative partner in the US, we had access to FRET (Fluorescence Resonance Energy Transfer) imaging technology," said Dr Paul Timpson.

"Until now, we have been limited to studying tumour signalling in two dimensions and lacked a dynamic way of reporting on drug targeting in live tumour tissue. Nanotechnology opens up a portal into living tissue that allows us to watch cancers spreading, and to determine which parts of a tumour we should be targeting with drugs."

"This imaging technology has allowed us to map areas within the tumour that are highly aggressive, allowing us to pinpoint regions of poor drug delivery deep within a tumour at sub-cellular resolution. We can then see where we need to improve on drug delivery to improve clinical outcome."

It has been hard to treat pancreatic tumours because they are extremely dense with collagen and have poor blood vessel networks for delivering drugs.

Professor Kurt Anderson observed that combination therapies can now be used to break down collagen, weakening tumour architecture and making it easier to get the drugs where they need to be. "The trick is to break down the structure just enough to get the drug in, but not so much that you damage the organ itself," he said.

"These new FRET technologies help us gauge what is just enough and not too much."

"These are very exciting discoveries we now have spatial and temporal information about cancer behaviour that we've never had before, as well as the nanotechnology to monitor and improve drug delivery in hard to reach tumour regions."


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Garvan Institute of Medical Research
Source:Eurekalert

Related biology news :

1. Purdue professor to speak before Congress about nanotechnology in brain treatment research
2. New study shows how nanotechnology can help detect disease earlier
3. Nanotechnology breakthrough could dramatically improve medical tests
4. Understanding the biological and ecological implications of safe nanotechnology
5. New study shows promise in using RNA nanotechnology to treat cancers and viral infections
6. Realizing the promise of RNA nanotechnology for new drug development
7. Mercury in water, fish detected with nanotechnology
8. European boost for DNA nanotechnology
9. Global Market for Nanotechnology to Reach $3.3 Trillion by 2018
10. Nanotechnology drug delivery shows promise for treatment of pediatric cancer
11. Bioengineer studying how to send drugs to lungs through nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2018)... ... August 21, 2018 , ... CRISPR-Cas9 gene editing strategies have ... for the robust functional interrogation of complex biological processes. Gene editing in primary ... the study of the autoimmunity, the understanding of host-pathogen dynamics that drive HIV ...
(Date:8/21/2018)... ... August 21, 2018 , ... Whether ... Bellbrook Labs is dedicated to offering customers a successful experience. When browsing ... a seamless transition between products, with relevant details such as technical manuals, application ...
(Date:8/15/2018)... ... , ... Exalto Bearings UK , the manufacturer of high quality rubber-lined ... quality management certification to BS EN ISO 9001:2015. This ISO standard is based on ... ability to offer products and services of consistent high quality. , Over the last ...
Breaking Biology News(10 mins):
(Date:8/21/2018)... ... August 21, 2018 , ... ... device compliance and commercialization, has just released a new paper discussing systems ... by Dr. Mario Kossmann, ESEP at the 28th Annual INCOSE International Symposium, ...
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the new ... Chemko Technical Services in 2016. Chemko had a well established local presence, servicing the ... KSC on projects such as the ongoing work at the Mobile Launch Platform (MLP) ...
(Date:8/17/2018)... VIEJO, Calif. (PRWEB) , ... August 16, 2018 ... ... quality genetic testing, announced their results from the AmbryShare project were published today ... candidate genes in the largest exome study ever conducted. , Every year hereditary ...
(Date:8/14/2018)... ... August 13, 2018 , ... Labconco Corporation manufactures laboratory equipment, ... In addition, Labconco produces other lab equipment, such as glassware washers and freeze ... and consistency in design and manufacturing. , Through this webinar, which is ...
Breaking Biology Technology: